Biocartis
Short position disclosed on June 16, 2023.
1.21% of the capital sold short
1 disclosing funds
80 disclosures on record
BE0974281132 ISIN code
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
January 10, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Whitebox Advisors LLC | 1.21% | unchanged | June 16, 2023 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 31, 2019 | Highbridge Capital Management LLC | 0.92% | January 3, 2020 |
| December 27, 2019 | Highbridge Capital Management LLC | 0.84% | December 31, 2019 |
| December 19, 2019 | Citadel Europe LLP | 2.53% | January 17, 2020 |
| November 29, 2019 | Citadel Europe LLP | 2.41% | December 19, 2019 |
| November 28, 2019 | Citadel Europe LLP | 2.36% | November 29, 2019 |
| November 19, 2019 | Highbridge Capital Management LLC | 0.72% | December 27, 2019 |
| November 7, 2019 | Highbridge Capital Management LLC | 0.64% | November 19, 2019 |
| October 7, 2019 | Citadel Europe LLP | 2.21% | November 28, 2019 |
| September 5, 2019 | Citadel Europe LLP | 2.19% | October 7, 2019 |
| September 5, 2019 | Highbridge Capital Management LLC | 0.50% | November 7, 2019 |
| August 27, 2019 | Highbridge Capital Management LLC | 0.59% | September 2, 2019 |
| August 13, 2019 | Citadel Europe LLP | 2.00% | September 5, 2019 |
| August 13, 2019 | Highbridge Capital Management LLC | 0.62% | August 27, 2019 |
| July 31, 2019 | Citadel Europe LLP | 1.73% | August 13, 2019 |
| July 19, 2019 | Highbridge Capital Management LLC | 0.77% | August 13, 2019 |
| July 2, 2019 | Citadel Europe LLP | 1.61% | July 31, 2019 |
| June 20, 2019 | Citadel Europe LLP | 1.52% | July 2, 2019 |
| June 20, 2019 | Highbridge Capital Management LLC | 0.87% | July 19, 2019 |
| June 13, 2019 | Citadel Europe LLP | 1.46% | June 20, 2019 |
| June 13, 2019 | Highbridge Capital Management LLC | 0.94% | June 20, 2019 |
| May 22, 2019 | Highbridge Capital Management LLC | 1.07% | June 13, 2019 |
| May 14, 2019 | Highbridge Capital Management LLC | 0.81% | May 22, 2019 |
| May 10, 2019 | Citadel Europe LLP | 1.20% | June 13, 2019 |
| May 10, 2019 | Highbridge Capital Management LLC | 0.70% | May 14, 2019 |
| May 9, 2019 | Citadel Europe LLP | 1.00% | May 10, 2019 |
| May 3, 2019 | Citadel Europe LLP | 0.91% | May 9, 2019 |
| May 3, 2019 | Millennium Capital Partners LLP | 0.55% | May 6, 2019 |
| May 2, 2019 | Citadel Europe LLP | 0.73% | May 3, 2019 |
| May 2, 2019 | Highbridge Capital Management LLC | 0.54% | May 10, 2019 |
| January 10, 2018 | Numeric Investors LLC | 0.50% | March 5, 2018 |
Other companies sold short in Belgium
- Solvay 2.07% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- D'Ieteren Group 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- EVS 0.80% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- WDP 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Biocartis, source FSMA, data as at June 16, 2023, https://www.quivad.com/action/biocartis?page=2